Actively Recruiting
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
Led by Indiana University · Updated on 2025-07-20
30
Participants Needed
3
Research Sites
487 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.
CONDITIONS
Official Title
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years old or older at the time of informed consent
- Written informed consent provided
- HIPAA authorization for release of personal health information
- Active diagnosis of Small Cell Lung Cancer
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, United States, 46202
Actively Recruiting
2
Roudebush VA Medical Center
Indianapolis, Indiana, United States, 46202
Actively Recruiting
3
Sidney and Lois Eskenazi Hospital
Indianapolis, Indiana, United States, 46202
Actively Recruiting
Research Team
G
Gabby Kline, BA
CONTACT
S
Shadia I. Jalal, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here